235 related articles for article (PubMed ID: 27868337)
1. Enhanced uptake of blood coagulation factor VIII containing immune complexes by antigen presenting cells.
Hartholt RB; Wroblewska A; Herczenik E; Peyron I; Ten Brinke A; Rispens T; Nolte MA; Slot E; Claassens JW; Nimmerjahn F; Verbeek JS; Voorberg J
J Thromb Haemost; 2017 Feb; 15(2):329-340. PubMed ID: 27868337
[TBL] [Abstract][Full Text] [Related]
2. To serve and protect: The modulatory role of von Willebrand factor on factor VIII immunogenicity.
Hartholt RB; van Velzen AS; Peyron I; Ten Brinke A; Fijnvandraat K; Voorberg J
Blood Rev; 2017 Sep; 31(5):339-347. PubMed ID: 28716211
[TBL] [Abstract][Full Text] [Related]
3. Anti-FcγRIIB (CD32) Antibodies Differentially Modulate Murine FVIII-Specific Recall Response in vitro.
Vollack N; Friese J; Bergmann S; Cragg MS; Tiede A; Werwitzke S
Scand J Immunol; 2017 Aug; 86(2):91-99. PubMed ID: 28561280
[TBL] [Abstract][Full Text] [Related]
4. Uptake of blood coagulation factor VIII by dendritic cells is mediated via its C1 domain.
Herczenik E; van Haren SD; Wroblewska A; Kaijen P; van den Biggelaar M; Meijer AB; Martinez-Pomares L; ten Brinke A; Voorberg J
J Allergy Clin Immunol; 2012 Feb; 129(2):501-9, 509.e1-5. PubMed ID: 21962992
[TBL] [Abstract][Full Text] [Related]
5. Fc Gamma Receptors and Complement Component 3 Facilitate Anti-fVIII Antibody Formation.
Zerra PE; Arthur CM; Chonat S; Maier CL; Mener A; Shin S; Allen JWL; Baldwin WH; Cox C; Verkerke H; Jajosky RP; Tormey CA; Meeks SL; Stowell SR
Front Immunol; 2020; 11():905. PubMed ID: 32582142
[TBL] [Abstract][Full Text] [Related]
6. Factor VIII antibody immune complexes modulate the humoral response to factor VIII in an epitope-dependent manner.
Batsuli G; Ito J; York ES; Cox C; Baldwin W; Gill S; Lollar P; Meeks SL
Front Immunol; 2023; 14():1233356. PubMed ID: 37720212
[TBL] [Abstract][Full Text] [Related]
7. Accelerated antigen presentation and elicitation of humoral response in vivo by FcgammaRIIB- and FcgammaRI/III-mediated immune complex uptake.
Yada A; Ebihara S; Matsumura K; Endo S; Maeda T; Nakamura A; Akiyama K; Aiba S; Takai T
Cell Immunol; 2003 Sep; 225(1):21-32. PubMed ID: 14643301
[TBL] [Abstract][Full Text] [Related]
8. Recombinant Factor VIII Fc Inhibits B Cell Activation via Engagement of the FcγRIIB Receptor.
Georgescu MT; Moorehead PC; Liu T; Dumont J; Scott DW; Hough C; Lillicrap D
Front Immunol; 2020; 11():138. PubMed ID: 32117285
[TBL] [Abstract][Full Text] [Related]
9. Fcγ receptor IIb strongly regulates Fcγ receptor-facilitated T cell activation by dendritic cells.
van Montfoort N; 't Hoen PA; Mangsbo SM; Camps MG; Boross P; Melief CJ; Ossendorp F; Verbeek JS
J Immunol; 2012 Jul; 189(1):92-101. PubMed ID: 22649202
[TBL] [Abstract][Full Text] [Related]
10. Long-term tolerance to factor VIII is achieved by administration of interleukin-2/interleukin-2 monoclonal antibody complexes and low dosages of factor VIII.
Liu CL; Ye P; Lin J; Djukovic D; Miao CH
J Thromb Haemost; 2014 Jun; 12(6):921-31. PubMed ID: 24684505
[TBL] [Abstract][Full Text] [Related]
11. A cellular viewpoint of anti-FVIII immune response in hemophilia A.
André S; Meslier Y; Dimitrov JD; Repessé Y; Kaveri SV; Lacroix-Desmazes S; Dasgupta S
Clin Rev Allergy Immunol; 2009 Oct; 37(2):105-13. PubMed ID: 19165635
[TBL] [Abstract][Full Text] [Related]
12. Immune tolerance induced by platelet-targeted factor VIII gene therapy in hemophilia A mice is CD4 T cell mediated.
Chen Y; Luo X; Schroeder JA; Chen J; Baumgartner CK; Hu J; Shi Q
J Thromb Haemost; 2017 Oct; 15(10):1994-2004. PubMed ID: 28799202
[TBL] [Abstract][Full Text] [Related]
13. Deletion or inhibition of Fc gamma receptor 2B (CD32) prevents FVIII-specific activation of memory B cells in vitro.
Werwitzke S; Vollack N; von Hornung M; Kalippke K; Kutzschbach J; Trummer A; Ganser A; Tiede A
Thromb Haemost; 2015 Nov; 114(6):1127-35. PubMed ID: 26245154
[TBL] [Abstract][Full Text] [Related]
14. Early cellular interactions and immune transcriptome profiles in human factor VIII-exposed hemophilia A mice.
Lai JD; Cartier D; Hartholt RB; Swystun LL; van Velzen AS; den Haan JMM; Hough C; Voorberg J; Lillicrap D
J Thromb Haemost; 2018 Mar; 16(3):533-545. PubMed ID: 29285874
[TBL] [Abstract][Full Text] [Related]
15. The impact of GPIbα on platelet-targeted FVIII gene therapy in hemophilia A mice with pre-existing anti-FVIII immunity.
Chen J; Schroeder JA; Luo X; Montgomery RR; Shi Q
J Thromb Haemost; 2019 Mar; 17(3):449-459. PubMed ID: 30609275
[TBL] [Abstract][Full Text] [Related]
16. The C1 and C2 domains of blood coagulation factor VIII mediate its endocytosis by dendritic cells.
Gangadharan B; Ing M; Delignat S; Peyron I; Teyssandier M; Kaveri SV; Lacroix-Desmazes S
Haematologica; 2017 Feb; 102(2):271-281. PubMed ID: 27758819
[TBL] [Abstract][Full Text] [Related]
17. Rapid desensitization of mice with anti-FcγRIIb/FcγRIII mAb safely prevents IgG-mediated anaphylaxis.
Khodoun MV; Kucuk ZY; Strait RT; Krishnamurthy D; Janek K; Clay CD; Morris SC; Finkelman FD
J Allergy Clin Immunol; 2013 Dec; 132(6):1375-87. PubMed ID: 24139828
[TBL] [Abstract][Full Text] [Related]
18. Anti-C1 domain antibodies that accelerate factor VIII clearance contribute to antibody pathogenicity in a murine hemophilia A model.
Batsuli G; Ito J; Mercer R; Baldwin WH; Cox C; Parker ET; Healey JF; Lollar P; Meeks SL
J Thromb Haemost; 2018 Sep; 16(9):1779-1788. PubMed ID: 29981270
[TBL] [Abstract][Full Text] [Related]
19. Factor VIII-Fc Activates Natural Killer Cells
Lagassé HAD; Hopkins LB; Jankowski W; Jacquemin MG; Sauna ZE; Golding B
Front Immunol; 2021; 12():692157. PubMed ID: 34262568
[TBL] [Abstract][Full Text] [Related]
20. von Willebrand factor modulates immune complexes and the recall response against factor VIII in a murine hemophilia A model.
Oleshko O; Vollack-Hesse N; Tiede A; Hegermann J; Curth U; Werwitzke S
Blood Adv; 2023 Nov; 7(21):6771-6781. PubMed ID: 37756521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
